NEW YORK ( TheStreet) -- CHANGE IN RATINGSBlackstone was initiated with a Buy rating at Stifel Nicolaus. $20 price target. Alternative investment strategies continue to attract assets, Stifel Nicolaus said. CH Robinson ( CHRW) was upgraded at Deutsche Bank from Hold to Buy. Valuation call, based on a $79 price target, Deutsche said. Comerica ( CMA) was downgraded at BMO from Outperform to Market Perform. Valuation call, based on a $36 price target, BMO said. Cree ( CREE) was downgraded at ThinkEquity from Buy to Hold. $30 price target. Estimates also cut, given the company's new guidance, ThinkEquity said. Deckers Outdoor ( DECK) was upgraded at Sterne Agee to Neutral. Valuation call, as the stock is down 30% since December, Sterne Agee said. Dun & Bradstreet ( DNB) was downgraded at JP Morgan from Neutral to Underweight. $75 price target. Company lacks near-term catalysts, JP Morgan said. First Solar ( FSLR) was downgraded at Wunderlich from Hold to Sell. $14 price target. Company is making a material change to its strategy, Wunderlich said. First Solar was upgraded from Sell to Hold at Cantor Fitzgerald. Valuation call, based on a $21.50 price target, Cantor said. Global Sources ( GSOL) was upgraded to Buy at TheStreet Ratings. Molycorp ( MCP) was upgraded to Hold at TheStreet Ratings. Walter Energy was initiated with a Buy rating at Bank of America/Merrill Lynch. $75 price target. Company has less energy exposure than its peers, BofA/Merrill Lynch said.
Stock Comments / EPS Changes
Apple ( AAPL) estimates, target boosted at Goldman Sachs. Shares are now seen reaching $750. Estimates were also increased, given higher expected iPhone and iPad sales, Goldman said. Buy rating. Comerica estimates, target were raised at Guggenheim. Estimates were increased through 2013. Company is focused on commercial loan growth, Guggenheim said. Buy rating and new $38 price target. Comerica numbers raised at Jefferies. Shares are now seen reaching $34. Estimates were also raised on better credit, Jefferies said. Hold rating. Cree estimates, target were reduced at Keybanc. Shares are now seen reaching $35. Estimates were also cut, given the company's new guidance, Keybanc said. Buy rating. Cree numbers were raised at Oppenheimer. Shares are now seen reaching $38. Estimates were also raised on slow quarter now in the rear view, Oppenheimer said. Outperform rating.